Advertisement

Genetics of the Alzheimer Amyloid Protein Precursor

  • Rachael L. Neve
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 265)

Abstract

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by gradual loss of memory, reasoning, orientation, and judgment (Katzman, 1983). AD generally occurs as a sporadic disorder of unknown cause. However, a proportion of cases, which have been termed familial Alzheimer’s disease (FAD), are caused by a genetic defect that is transmitted in an autosomal dominant fashion (Heston et al., 1981), and that has been mapped to chromosome 21 (St. George-Hyslop, 1987a). One of the hallmarks of AD is the presence of numerous neuritic plaques in postmortem brain tissue that are revealed by neuropathological examination (Glenner, 1983). The degree of intellectual impairment in patients appears to be correlated with the frequency of neuritic plaques in the cortex (Roch et al., 1966). The mature neuritic plaque consists of degenerating axons and neurites surrounding an amyloid plaque core (APC) composed of 5- to 10-nm filaments (Mertz et al., 1983) that stain with Congo red (Terry et al., 1981). Similar filaments are also found outside of plaques as independent bundles in the cortical neuropil and in the walls of meningeal and intracortical blood vessels [termed cerebrovascular amyloid (CVA)] (Glenner, 1983). A 4.2-kD polypeptide, called the β protein (due to its partial β-pleated sheet structure), has been isolated from both CA and APC. An identical 28-amino acid sequence (with the exception of a Glu to Gln substitution) was obtained from the CA and APC β proteins, suggesting a possible common origin for both types of amyloid (Glenner and Wong, 1984a, 1984b; Masters et al., 1985). The brains of aged individuals with Down syndrome (DS, trisomy 21) also have both APC and CA that contain a β protein with the same stretch of 28 amino acids (Glenner and Wong, 1984b; Masters et al., 1985); this similarity indicates that a common mechanism may underlie the formation of amyloid in AD and DS.

Keywords

Down Syndrome Amyloid Protein Precursor Neuritic Plaque Cornu Ammonis Amyloid Protein Precursor Gene 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ball MJ. Acta Neoropathol 1978; 42: 73–80.CrossRefGoogle Scholar
  2. Burger PC. In: Katzman R, ed. Banbury Report 15: Biological Aspects of Alzheimer’s Disease. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1983; pp. 37–44.Google Scholar
  3. Cohen ML, Golde TE, Usiak MF, Younkin LH, Younkin SG. Proc Natl Acad Sci USA 1988; 85: 1227–1231.CrossRefGoogle Scholar
  4. Gibson PH. Neuropathol Appl Neurobiol 1983; 9: 379–389.CrossRefGoogle Scholar
  5. Glenner G. Arch Pathol Lab Med 1983; 107: 281–282.Google Scholar
  6. Glenner GG, Wong CW. Biochem Biophys Res Commun 1984; 120: 885–890.CrossRefGoogle Scholar
  7. Glenner GG, Wong CW. Biochem Biophys Res Commun 1984; 122: 1131–1135.CrossRefGoogle Scholar
  8. Goedert M. The EMBO J 1987; 6: 3627–3632.Google Scholar
  9. Goldgaber D, Lerman MI, McBride W, Saffiotti U, Gajdusek DC. Science 1987; 235: 877–880.CrossRefGoogle Scholar
  10. Heston LL, Mastri AR, Anderson VE, White J. Arch Gen Psychiatry 1981; 38: 1085.CrossRefGoogle Scholar
  11. Higgins GA, Dawes LR, Neve RL. Soc Neurosci Abst 1988; 14: 637.Google Scholar
  12. Higgins GA, Lewis DA, Bahmanyar S, Goldgaber D, Gajdusek DC, Young WG, Morrison JH, Wilson MC. Proc Nàtl Acad Sci USA 1988; 85: 1297–1301.CrossRefGoogle Scholar
  13. Hyman BT, Van Hoesen GW, Kormer LS, Damasio AR. Ann Neurol 1986; 20: 472–479CrossRefGoogle Scholar
  14. Kang J, Lemaire H-G, Unterbeck A, Salbaum MJ, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Muller-Hill B. Nature 1987; 325: 733–736.CrossRefGoogle Scholar
  15. Katzman R, (ed.) Banbury Report 15: Biological Aspects of Alzheimer’s Disease (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1983). Kitaguchi N, Takahashi Y, Tokushima Y, Shiojiri S, Ito H. Nature 1988; 331: 530–532.Google Scholar
  16. Lewis DA, Campbell MJ, Terry RD, Morrison JH. J Neurosci 1987; 7: 1799.Google Scholar
  17. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K Proc Natl Acad Sci USA 1985; 82: 4245–4249.CrossRefGoogle Scholar
  18. Mlandybar TI. Neurology 1975; 25: 120–126.CrossRefGoogle Scholar
  19. Morimatsu M et al. J Am Geriatr Soc 1975; 23: 390–406.Google Scholar
  20. Neve RL, Kosik KS, Kurnit DM, Donlon TA. Mol Brain Res 1986; 1: 271–280CrossRefGoogle Scholar
  21. Neve RL, Finch EA, Dawes LR. Neuron 1988; in press.Google Scholar
  22. Palmert MR, Golde TE, Cohen ML, Kovacs DM, Tanzi RE, Gusella JF, Usiak MF, Younkin LH, Younkin SG. Science 1988; 241: 1080–1084.CrossRefGoogle Scholar
  23. Pearson RCA, Esiri MM, Hiorns RW, Wilcock GK, Powell TPS. Proc Natl Acad Sci USA 1985; 82: 4531–4534.CrossRefGoogle Scholar
  24. Podlisney MB, Lee G, Selkoe DJ. Science 1987; 238: 669–671.CrossRefGoogle Scholar
  25. Ponte P, Gonzalez-DeWhitt P, Schilling J, Miller J, Hsu D, Greenberg B, Davis K, Wallace W, Lieberburg I, Fuller F, Cordell B. Nature 1988; 331: 525–527.CrossRefGoogle Scholar
  26. Robakis NK, Ramakrinshna N, Wolfe G, Wisniewski HM. Proc Natl Acad Sci USA 1987; 84: 4190–4194.CrossRefGoogle Scholar
  27. Roch M, Tomlinson BE, Blessed G. Nature (London) 1966; 209: 109–110.CrossRefGoogle Scholar
  28. St. George-Hyslop PH, Tanzi RE, Polinsky RJ, Haines JL, Nee L, Watkins PC, Myers RH, Feldman RG, Pollen D, Drachman D, Growdon J, Bruni A, Foncin JF, Salmon D, Frommelt P, Amaducci L, Sorbi S, Piacentini S, Stewart CD, Hobbs WJ, Conneally PM, Gusella JF. Science 1987a; 235: 885–890.Google Scholar
  29. St. George-Hyslop PH, Tanzi RE, Polinsky RJ, Neve RL, Pollen D, Drachman D, Growdon J, Cupples LA, Nee L, Myers RH, O’Sullivan D, Watkins PC, Amos JA, Deutsch CK, Bodfish JW, Kinsbourne M, Feldman RG, Bruni A, Amaducci L, Foncin J-F, Gusella JF. Science 1987b; 238: 664–666.Google Scholar
  30. Tanzi RE, Gusella JF, Watkins PC, Bruns GAP, St. George-Hyslop P, Van Keuren ML, Patterson D, Pagan S, Kurnit DM, Neve RL. Science 1987a; 329: 156–157.Google Scholar
  31. Tanzi RE, St. George-Hyslop PH, Haines JL, Polinsky RJ, Nee L, Foncin JF, Neve RL, McClatchey AI, Conneally PM, Gusella JF. Nature 1987b; 329: 156–157.CrossRefGoogle Scholar
  32. Tanzi RE, Bird ED, Latt SA, Neve RL. Science 1987c; 238: 666–669.CrossRefGoogle Scholar
  33. Tanzi RE, McClatchey AI, Lamberti ED, Villa-Komaroff L, Gusella JF, Neve RL. Nature 1988; 331: 528–530.CrossRefGoogle Scholar
  34. Terry RD, Peck A, DeTeresa R, Schechter R, Horoupian DS. Ann Neurol 1981; 10: 184–192.CrossRefGoogle Scholar
  35. Van Broeckhoven C, Genthe AM, Vandenberghe A, Horsthemke B, Backhoven H, Raeymaekers P, Van Hul W, Wehnert A, Gheuens J, Gras P, Bruyland M, Martin JJ, Salbaum M. Nature 1987; 329: 153–155.CrossRefGoogle Scholar
  36. Vinters HV, Gilbert JJ. Stroke 1983; 14: 924–928.CrossRefGoogle Scholar
  37. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, DeLong MR. Science 1982; 215: 1237–1239.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1990

Authors and Affiliations

  • Rachael L. Neve
    • 1
  1. 1.Division of GeneticsThe Children’s HospitalBostonUSA

Personalised recommendations